Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1481
Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis
Published 2013“…The relative expression (2<sup>-ΔΔCt</sup> mean ± SEM) of hepatic CYP3A4 mRNA was significantly higher in cirrhotic livers (21.76 ± 2.65 vs. 5.91 ± 1.29, P=2.04E-07) but their levels did not significantly correlate with hepatic CYP3A activity (r=-0.43, P=0.08).…”
-
1482
-
1483
-
1484
-
1485
-
1486
-
1487
-
1488
-
1489
-
1490
-
1491
Deterioration of the anammox process at decreasing temperatures and long SRTs
Published 2017“…The long SRT leads to an increase of non-active and non-anammox cells in the reactor, thereby decreasing the biomass-specific activity.…”
-
1492
-
1493
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
1494
-
1495
-
1496
ANG II treatment leads to decreased contractile function.
Published 2016“…(E) Representative stress traces generated from x-projections of films (F) ANG II treatment leads to a decrease in contractile stress generation. Control n = 85 tissues, 5 nM n = 15 tissues, 100 nM n = 69 tissues, 3 harvests. …”
-
1497
-
1498
EGCG decreases RSK2-mediated cell viability.
Published 2015“…Differences were evaluated using the Student’s t-test and the asterisk (*) indicates a significant decrease in viability in RSK2<sup>+/+</sup> MEFs compared to RSK2<sup>-/-</sup> MEFs (<i>p</i> < 0.05).…”
-
1499
Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin.
Published 2013“…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”
-
1500